Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00496366
Status:
TERMINATED
Last Update Posted:
2017-03-21
First Post:
2007-07-03
Brief Title:
Capecitabine Xeloda and Lapatinib Tykerb as First-line Therapy in HER2Neu-positive Breast Cancer
Sponsor:
Organization:
Rutgers The State University of New Jersey